Y. Baruch et al., SPONTANEOUS PULSATILITY AND PHARMACOKINETICS OF GROWTH-HORMONE IN LIVER CIRRHOTIC-PATIENTS, Journal of hepatology, 29(4), 1998, pp. 559-564
Background/Aims: Liver cirrhosis is characterized by high serum growth
hormone levels and low serum insulin-like growth factor I and growth
hormone-binding protein levels, The present study was designed to char
acterize the serum profile of growth hormone and growth hormone pharma
cokinetics in postnecrotic liver cirrhosis, correlating it with liver
function and nutritional states. Methods: Fifteen patients were groupe
d by the Child-Pugh score (group 1, score of 5 to 8; group 2, score of
9 to 12). Five healthy subjects served as controls. Nutritional statu
s was assessed by the creatinine-height index. Baseline growth hormone
, insulin-like growth factor, and growth hormone binding protein were
measured, and growth hormone pharmacokinetics was followed for 48 h af
ter administration of subcutaneous recombinant human growth hormone (0
.06 mg/kg).Results: Trough serum growth hormone (mu g/l) was higher in
both patient groups (5.3+/-3.6) than in controls (1.0+/-0.3; p<0.01).
More pulses were recorded in cirrhotic patients and mean pulse amplit
ude (mu g/l) was higher in cirrhotic patients than in controls (p<0.01
). After subcutaneous recombinant human growth hormone injection, maxi
mal growth hormone was higher in cirrhotic patients and the area under
the curve over 24 h was greater (626+/-120) than in controls (330+/-5
4; p<0.01). Single regression analysis showed a weak correlation of bo
th the Child-Pugh score and the creatinine-height index with the pharm
acokinetic parameters. Conclusions: Due to decreased growth hormone cl
earance, patients with liver cirrhosis have increased trough and peak
serum growth hormone levels, as well as lower serum growth hormone bin
ding protein and insulin-like growth factor. Recombinant human growth
hormone pharmacokinetics are typical of a high hepatic extraction subs
tance administered to patients with liver disease and portal hypertens
ion, and this may be relevant to the further use of growth hormone the
rapy.